Cargando…
Effect of ranibizumab on serous and vascular pigment epithelial detachments associated with exudative age-related macular degeneration
PURPOSE: To report the effect of intravitreal ranibizumab therapy for serous and vascular pigment epithelial detachments (PED) associated with choroidal neovascularisation (CNV) secondary to age-related macular degeneration (AMD). METHODS: In a prospective study, best-corrected visual acuity (BCVA)...
Autores principales: | Panos, Georgios D, Gatzioufas, Zisis, Petropoulos, Ioannis K, Dardabounis, Doukas, Thumann, Gabriele, Hafezi, Farhad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3712738/ https://www.ncbi.nlm.nih.gov/pubmed/23874084 http://dx.doi.org/10.2147/DDDT.S46610 |
Ejemplares similares
-
Anti-VEGF Agents for the Treatment of Pigment Epithelial Detachments Associated with Neovascular Age-related Macular Degeneration: An Evidence-based Approach
por: Panos, Georgios D., et al.
Publicado: (2015) -
Ranibizumab for the treatment of degenerative ocular conditions
por: Triantafylla, Magdalini, et al.
Publicado: (2014) -
Effectiveness of Intravitreal Injection of Ranibizumab for Neovascular Age-Related Macular Degeneration with Serous Pigment Epithelial Detachment
por: Zhao, Chun, et al.
Publicado: (2016) -
Treatment of retinal pigment epithelial detachment secondary to exudative age-related macular degeneration
por: Gonzalez, Andres, et al.
Publicado: (2017) -
Effectiveness of Intravitreal Ranibizumab for Diabetic Macular Edema with Serous Retinal Detachment
por: Kaya, Mahmut, et al.
Publicado: (2018)